AC
AbelZeta Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Not Specified (Hematologic Malignancies) | Hematologic Malignancies | Clinical |
| Not Specified (Inflammatory & Immunological) | Inflammatory & Immunological Diseases | Clinical |
| Not Specified (Solid Tumors) | Solid Tumors | Clinical |
Leadership Team at AbelZeta Pharma
T(
Tony (Bizuo) Liu
Chairman and CEO
YY
Yihong Yao, Ph.D., BS
Chief Scientific Officer
MH
Michael Havert, Ph.D.
Senior Vice President, Regulatory Affairs & Quality, US
JH
Jiaqi Huang, MD, Ph.D.
Senior Vice President, Translational Medicine
MM
Matt Mandel, MD
Senior Vice President, Clinical